We propose that the relative activity of JNK1 versus JNK2 sets a molecular switch that determines AP-1 dimer identity at SASP promoters, thereby deciding whether a cell resolves stress or commits to senescence. In acute infection, JNK1 limits early inflammation while JNK2 drives neutrophil recruitment 4. We hypothesize that sustained stress shifts the JNK1/JNK2 ratio toward JNK2 dominance, favoring phosphorylation of ATF2 over c-Jun at specific serine residues. This altered phosphorylation landscape promotes c‑Jun/ATF2 heterodimers, which have higher affinity for κB‑like elements in SASP gene enhancers compared with c‑Jun/c‑Fos dimers that preferentially bind transient‑response promoters. Consequently, a JNK2‑biased state locks AP-1 into a SASP‑activating configuration, whereas a balanced or JNK1‑biased state permits rapid dimer turnover and gene repression after stress removal.

Key mechanistic steps

1. Signal duration sensing – Prolonged oxidative or ER stress maintains ASK1 activation, which preferentially phosphorylates and activates JNK2/3 over JNK1 5.
2. Differential substrate phosphorylation – JNK2 exhibits higher catalytic efficiency toward ATF2 (Thr‑69/71) than JNK1, while JNK1 phosphorylates c‑Jun (Ser‑63/73) with comparable efficiency to JNK2 1.
3. AP-1 dimer selection – Phospho‑ATF2 stabilizes c‑Jun/ATF2 heterodimers, which recruit co‑activators (e.g., CBP/p300) to SASP promoters containing AP‑1/κB composite sites. Phospho‑c‑Jun favors c‑Jun/c‑Fos dimers that bind AP‑1 sites driving immediate‑early genes (e.g., GADD45β, DUSP1).
4. Feedback lock – SASP‑secreted IL‑1α and IL‑1β reinforce ASK1/JNK2 signaling via autocrine loops, creating a bistable system where the JNK2‑high/ATF2‑phospho state is self‑reinforcing.

Testable predictions

• Prediction 1: In primary human fibroblasts exposed to low‑dose etoposide for 6 h (transient stress), JNK1 activity will exceed JNK2, c‑Jun phosphorylation will dominate, and c‑Jun/c‑Fos will be the predominant AP‑1 complex at SASP promoters (measured by ChIP‑seq). After 48 h (sustained stress), JNK2 activity will surpass JNK1, ATF2 phosphorylation will rise, and c‑Jun/ATF2 occupancy will increase at IL6, IL8, and MMP3 promoters.
• Prediction 2: siRNA‑mediated knock‑down of JNK2 (but not JNK1) in senescent cells will reduce ATF2 phosphorylation, shift AP‑1 dimer composition toward c‑Jun/c‑Fos, and decrease SASP mRNA levels without affecting p16^INK4a^ expression.
• Prediction 3: Expression of a phospho‑deficient ATF2 mutant (T69A/T71A) in cells subjected to chronic oxidative stress will prevent the JNK2‑driven dimer switch, attenuate SASP induction, and allow cells to recover after stress removal.

Experimental approach

• Use isoform‑specific JNK inhibitors (SP600125 for JNK1/2, with JNK2‑selective peptide inhibitor) and isoform‑specific siRNAs to manipulate JNK1/JNK2 ratios.
• Quantify phospho‑c‑Jun (Ser‑63/73) and phospho‑ATF2 (Thr‑69/71) by Western blot and flow cytometry.
• Perform AP‑1 dimer‑specific ChIP‑seq using antibodies against c‑Jun, c‑Fra‑1, and ATF2, followed by motif analysis to assign dimer binding preferences.
• Measure SASP cytokine secretion (ELISA) and senescence markers (SA‑β‑gal, p16) to correlate dimer shifts with functional outcomes.

If the JNK1/JNK2 ratio indeed governs AP-1 dimer composition and thereby the binary choice between transient stress adaptation and permanent SASP, then modulating isoform balance should offer a lever to attenuate inflammaging without abolishing acute host defense.